stars 1 stars 2 stars 3

Hylomorph is an innovative Medtech company engineering innovative medical devices and drug-device combos that prevent implant complications and ensure patients' well-being post-surgery. At Hylomorph, we believe that every person deserves access to the best possible healthcare. That is why we are committed to developing innovative solutions that address medical needs and improve patient outcomes. By leveraging cutting-edge technologies and collaborating with healthcare professionals, we strive to make a positive impact in the lives of individuals and their families. We aim at preventing post operative complications in implantable medical devices. Our mission is to improve quality of life in patients and the quality of care by health professionals.

Hylomorph Questions

The Hylomorph annual revenue was $200000 in 2026.

Simone Bottan is the CEO of Hylomorph.

10 people are employed at Hylomorph.

Hylomorph is based in Zurich, Zurich.

The NAICS codes for Hylomorph are [339, 33].

The SIC codes for Hylomorph are [38, 384].

Top Hylomorph Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users